Cleared Traditional

K242378 - Eclipse Treatment Planning System (18.1)

K242378 is an FDA 510(k) clearance for Eclipse Treatment Planning System (18.1), manufactured by Varian Medical Systems. The device is a Class 2 Radiology device with product code MUJ cleared through the Traditional 510(k) pathway after a 124-day FDA review.

K242378 · Varian Medical Systems · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2024
Decision
124d
Days
Class 2
Risk

K242378 is an FDA 510(k) clearance for the Eclipse Treatment Planning System (18.1). Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Varian Medical Systems (Palo Alto, US). The FDA issued a Cleared decision on December 11, 2024 after a review of 124 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Varian Medical Systems devices

FDA 510(k) Submission Details - K242378

510(k) Number K242378 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 09, 2024
Decision Date December 11, 2024
Days to Decision 124 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d slower than avg
Panel avg: 107d · This submission: 124d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MUJ Device Classification - Class 2, Special Controls

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 207
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K242378.
RayStation 2023B, RayPlan 2023B, RayStation 2024A, RayPlan 2024A, RayStation 2024A SP3, RayPlan 2024A SP3
K240398 · RaySearch Laboratories AB (PUBL) · Apr 2025
ART-Plan+ (v.3.0.0)
K242822 · Therapanacea Sas · Feb 2025
ARIA Radiation Therapy Management System (18.1)
K242463 · Varian Medical Systems, Inc. · Dec 2024
XBeam (v2)
K240671 · Xstrahl, Ltd. · Dec 2024
Vitesse (5.0)
K241876 · Varian Medical Systems · Oct 2024
TrueFit Bolus
K243057 · Adaptiiv Medical Technologies, Inc. · Oct 2024